+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Transplantation"

From
From
Transplantation - Global Strategic Business Report - Product Thumbnail Image

Transplantation - Global Strategic Business Report

  • Report
  • April 2025
  • 232 Pages
  • Global
From
Fecal Microbiota Transplantation (FMT) Market Report 2025 - Product Thumbnail Image

Fecal Microbiota Transplantation (FMT) Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
3D Cell Culture Market - Global Outlook & Forecast 2024-2029 - Product Thumbnail Image

3D Cell Culture Market - Global Outlook & Forecast 2024-2029

  • Report
  • October 2024
  • 349 Pages
  • Global
From
Global Cell Therapy Biomanufacturing Market 2024-2029 - Product Thumbnail Image

Global Cell Therapy Biomanufacturing Market 2024-2029

  • Report
  • August 2024
  • 112 Pages
  • Global
From
Global Cell Separation Technology Market Outlook 2037 - Product Thumbnail Image

Global Cell Separation Technology Market Outlook 2037

  • Report
  • June 2024
  • 360 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Transplantation market within the context of Biotechnology is focused on the development of treatments and technologies that enable the successful transfer of organs, tissues, and cells from one individual to another. This includes the development of new methods for organ preservation, the development of new immunosuppressive drugs, and the development of new technologies for organ matching. Additionally, the market is focused on the development of new methods for organ harvesting, as well as the development of new methods for organ transplantation. The Transplantation market is a rapidly growing sector of the biotechnology industry, with many companies investing in research and development to improve the success rate of organ transplants. Companies in this market include Organogenesis, Organovo, Histogenics, and United Therapeutics. Additionally, many pharmaceutical companies are investing in the development of new immunosuppressive drugs to improve the success rate of organ transplants. Show Less Read more